Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Other Working Capital Changes (2023 - 2025)

Bioharvest Sciences has reported Other Working Capital Changes over the past 3 years, most recently at $53000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes changed N/A year-over-year to $53000.0; the TTM value through Dec 2025 reached -$415000.0, changed N/A, while the annual FY2025 figure was -$415000.0, 320.74% down from the prior year.
  • Other Working Capital Changes was $53000.0 for Q4 2025 at Bioharvest Sciences, up from -$553000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $224000.0 in Q1 2025 and bottomed at -$1.4 million in Q4 2023.
  • The 3-year median for Other Working Capital Changes is -$43000.0 (2025), against an average of -$297166.7.
  • The widest YoY moves for Other Working Capital Changes: up 267.21% in 2025, down 267.21% in 2025.
  • Over 3 years, Other Working Capital Changes stood at -$1.4 million in 2023, then soared by 104.27% to $61000.0 in 2024, then dropped by 13.11% to $53000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $53000.0 (Q4 2025), -$553000.0 (Q3 2025), and -$139000.0 (Q2 2025) per Business Quant data.